| Karla Garcia, DMD | |
|
628 N Bear Lake Rd, Apopka, FL 32703-8807 | |
| (407) 862-1231 | |
| Not Available |
| Full Name | Karla Garcia |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 628 N Bear Lake Rd, Apopka, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831870021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DN27967 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karla Garcia, DMD 3119 Black Pine Ave, Winter Park, FL 32792-6646 Ph: (407) 681-5890 | Karla Garcia, DMD 628 N Bear Lake Rd, Apopka, FL 32703-8807 Ph: (407) 862-1231 |
News Archive
The system has grown rapidly since its launch in 2005 to become the industry standard product of its type. It is now used in 600 wards across 45 hospitals with over five million sets of observations being collected each month.
BioTime, Inc. today reported financial results for the first quarter ended March 31, 2010 and provided an update on recent corporate developments.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
› Verified 4 days ago
Rewan Bowen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1585 Rock Springs Rd, Apopka, FL 32712 Phone: 407-884-1846 | |
Dr. Khaled Daoud Hamdallah, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 2216 E Semoran Blvd, Apopka, FL 32703 Phone: 407-889-4360 | |
Mrs. Ericka Shelly Lowe, DMD, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 660 Executive Park Ct Ste 1600, Apopka, FL 32703 Phone: 407-930-4496 Fax: 321-972-2443 | |
Dr. Francisco Vicente Chumpitaz, DDS Dentist Medicare: Medicare Enrolled Practice Location: 380b Semoran Commerce Pl Ste 204, Apopka, FL 32703 Phone: 201-284-2806 | |
Dr. Kirk Kenneth Cohil, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2525 E Semoran Blvd, Apopka, FL 32703 Phone: 407-889-9682 Fax: 407-889-0015 | |
Dr. Linda Kulma Russow, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2216 E Semoran Blvd, Apopka, FL 32703 Phone: 407-529-4973 Fax: 407-889-2037 | |
Dr. Kenneth George Chen, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 225 Copper Oak Ct, Apopka, FL 32703 Phone: 760-845-6334 |